PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsFamilial mediterranean fever
MeSH D010505 - familial mediterranean fever
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D056660:Hereditary autoinflammatory diseases
0 Companies
0 Drugs
Success rate
D010505: 
Familial mediterranean fever
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Novast LaboratoriesColchicine, Probenecid Probenecid Colchicine  2008-05-13   
MylanColchicine Colchicine  2019-09-16   
SandozColchicine, Probenecid Probenecid Colchicine  1982-01-01   
NovartisCanakinumab Ilaris  2009-06-17 $1,206 M Q2/21-Q2/24 
Merck & CoColchicine, Probenecid Colbenemid  1982-01-01   
TakedaColchicine Colcrys 2028-10-06 2009-07-29   
Aurobindo PharmaColchicine Colchicine  2022-01-06   
Dr Reddys LaboratoriesColchicine Colchicine  2019-09-06   
Zydus TherapeuticsColchicine Colchicine  2019-02-19   
Alkem LaboratoriesColchicine Colchicine  2019-02-08   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
20%
1/5
Phase 3
67%
2/3
Approved: 2Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
Merck & Co
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use